NEW YORK, March 31 /PRNewswire-FirstCall/ -- Cadus Corporation (OTC Bulletin Board: KDUS) announced today financial results for the fourth quarter and full year ended December 31, 2007.

Revenues for the full year 2007 were $100,000, compared to $100,000 for the full year 2006. Net loss for the full year 2007 was $272,110, compared to net income of $446,194 for the full year 2006. Basic and diluted net loss per share for the full year 2007 was $0.02, compared to basic and diluted net income per share for the full year 2006 of $0.03. The decrease in net income and basic and diluted net income per share for the full year 2007 was attributable to a $668,246 loss on the sale of Sequenom, Inc. stock and a $320,362 reduction in the value of short term investments to net asset value, offset by an increase of $115,975 in interest income and in income in other ventures of $1,342 and decreases in general and administrative expenses of $151,513 and in taxes of $1,474.

Revenues for the fourth quarter of 2007 were $0, compared to $0 for the same period in 2006. Net loss for the fourth quarter of 2007 was $172,828, compared to net income of $69,661, for the same period in 2006. Basic and diluted net loss per share for the fourth quarter of 2007 was $0.02, compared to basic and diluted net income per share for the fourth quarter of 2006 of $0.01.

As of December 31, 2007, Cadus had 13,144,040 shares outstanding.

This press release may contain forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's annual report on Form 10-K for the year ended December 31, 2007. These include risks and uncertainties relating to the company's ability to license its technologies to third parties, the company's capital needs and uncertainty of future funding, the company's history of operating losses, the unpredictability of patent protection and the risk of obsolescence of the company's technologies.




                               (Tables Follow)



                       Cadus Corporation and Subsidiary

                         Consolidated Balance Sheets

                                    ASSETS

                                               December 31,     December 31,
                                                  2007             2006

    Current assets:
      Cash and cash equivalents                $2,444,376       $24,602,202
      Short term investments                   22,960,545                -
      Interest receivable                         102,518                -
      Prepaid and other current assets              1,150             5,210
      Investment in marketable securities              -            628,585

         Total current assets                  25,508,589        25,235,997

    Investment in other ventures                  186,790           173,427
    Patents, net                                  550,834           637,267
         Total assets                         $26,246,213       $26,046,691

             LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:
      Accrued expenses and other
      current liabilities                         $22,352           $61,307

         Total current liabilities                 22,352            61,307

    Commitments and contingencies

    Stockholders' equity:
      Common stock                                132,857           132,857
      Additional paid-in capital               59,847,149        59,844,355
      Accumulated deficit                     (33,456,070)      (33,183,960)
      Accumulated other comprehensive
       (loss) income                                   -           (507,793)
      Treasury stock                             (300,075)         (300,075)
        Total stockholders' equity             26,223,861        25,985,384
        Total liabilities stockholder's
         equity                               $26,246,213       $26,046,691



                       Cadus Corporation and Subsidiary

               Condensed Consolidated Statements of Operations

                                  Three Months Ended
                                      December 31,           Year Ended
                                      (unaudited)            December 31,
                                   2007        2006        2007        2006

    License and maintenance fees   $ --        $ --     $100,000    $100,000

         Total revenues              --          --      100,000     100,000

    Costs and expenses:
      General and administrative
       expenses                   92,739     170,986     557,938     709,451
      Amortization of patent
       costs                      21,609      21,609      86,433      86,433
      (Income) from equity in
       other ventures             (3,374)     (3,353)    (13,363)    (12,021)

     Total costs and expenses    110,974     189,242     631,008     783,863

    Operating (loss)            (110,974)   (189,242)   (531,008)   (683,863)

    Other income (expense):
      Interest income            322,517     325,154   1,312,283   1,196,308
      Loss on sale of
       marketable securities         --          --     (668,246)       --
      Investment reduction to
       net asset value          (320,362)        --     (320,362)       --
      Total other income           2,155     325,154     323,675   1,196,308

    (Loss) income before
     income tax provision       (108,819)    135,912    (207,333)    512,445

    Provision for franchise
     and income taxes             64,009      66,251      64,777      66,251

    Net (loss) income          $(172,828)    $69,661   $(272,110)   $446,194

    Basic and diluted net
     (loss) income per share      $(0.02)      $0.01      $(0.02)      $0.03

    Weighted average shares of
     common stock outstanding
     - basic and diluted      13,144,040  13,144,040  13,144,040  13,144,040

SOURCE Cadus Corporation